Structural changes of the ligand and of the receptor alters the receptor preference for neutrophil activating peptides starting with a formylmethionyl groupHuamei Forsman, Cláes Dahlgren, Malene Winther et al.|Biochimica et Biophysica Acta (BBA) - Molecular Cell Research|2014Cited by 41
A Pepducin Derived from the Third Intracellular Loop of FPR2 Is a Partial Agonist for Direct Activation of This Receptor in Neutrophils But a Full Agonist for Cross-Talk Triggered Reactivation of FPR2Michael Gabl, Huamei Forsman, Malene Winther et al.|PLoS ONE|2014Cited by 31
The proteolytically stable peptidomimetic Pam-(Lys-βNSpe)6-NH2 selectively inhibits human neutrophil activation via formyl peptide receptor 2Sarah Line Skovbakke, Cláes Dahlgren, Henrik Franzyk et al.|Biochemical Pharmacology|2014Cited by 22
The peptidomimetic Lau-(Lys-βNSpe)6-NH2 antagonizes formyl peptide receptor 2 expressed in mouse neutrophilsSarah Line Skovbakke, Huamei Forsman, Malene Winther et al.|Biochemical Pharmacology|2016Cited by 19
The Lipidated Peptidomimetic Lau-((S)-Aoc)-(Lys-βNphe)6-NH2 Is a Novel Formyl Peptide Receptor 2 Agonist That Activates Both Human and Mouse Neutrophil NADPH OxidaseAndré Holdfeldt, Henrik Franzyk, Sarah Line Skovbakke et al.|Journal of Biological Chemistry|2016Cited by 18